Fact sheet: BB Medtech

Fund information

Fund name
BB Medtech B EUR
Fund company manager
Bellevue Asset Management
Fund type
SIB
Fund manager
John Manieri
since 01/03/2016
Fund objective
The Fund’s investment objective is to generate attractive and competitive capital growth in the long term. It is therefore particularly suited to investors with an investment horizon of at least 5 years who want to selectively diversify their portfolio with investments in the medtech sector and who are willing to accept the equity risk typical of this sector.
Benchmark
No Specified Index
Investment style
None
Investment method
Shares

Quick stats

1 Year return

11.33 %

1 Year rank in sector

11/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 180.3 m

FE Risk score

128

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    87.8%
  • Denmark
    3.4%
  • Others
    2.3%
  • Money Market
    2.2%
  • Japan
    2.1%
  • Health Care
    78.9%
  • Others
    14.1%
  • Biotechnology/Medical
    4.8%
  • Money Market
    2.2%
  • US Equities
    87.8%
  • Danish Equities
    3.4%
  • International Equities
    2.3%
  • Money Market
    2.2%
  • Japanese Equities
    2.1%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-3.41 %10.76 %10.66 %66.57 %109.51 %
Sector1.43 %13.25 %10.11 %31.73 %106.74 %
Rank within sector26 / 3019 / 2911 / 293 / 2611 / 23
Quartile th4 th3 rd2 nd1 st2 nd

Calendar performance

YTD-20172016201520142013
Fund14.12 %6.5 %10.88 %35.42 %15.54 %
Sector16.33 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector18 / 293 / 298 / 279 / 2423 / 23
Quartile th3 rd1 st2 nd2 nd4 th

Risk statistics

Alpha11.96
Beta0.74
Sharpe1.1
Volatility13.89
Tracking error9.07
Information ratio1.05
R-Squared0.68

Price movement

52 week high373.86
52 week low298.71
Current bid price0
Current offer price0
Current mid price360.14

Holdings by region

  • 87.8% USA
  • 3.4% Denmark
  • 2.3% Others
  • 2.2% Money Market
  • 2.1% Japan
  • 1.2% Germany
  • 1% Netherlands

Holdings by sector

  • 78.9% Health Care
  • 14.1% Others
  • 4.8% Biotechnology/Medical
  • 2.2% Money Market

Holdings by asset type

  • 87.8% US Equities
  • 3.4% Danish Equities
  • 2.3% International Equities
  • 2.2% Money Market
  • 2.1% Japanese Equities
  • 1.2% German Equities
  • 1% Dutch Equities

Individual holdings

  • 8.8% MEDTRONIC INC
  • 8% ABBOTT LABORATORIES
  • 6.8% BOSTON SCIENTIFIC CORP
  • 5.9% DANAHER CORP
  • 4.7% ZIMMER BIOMET HLDGS INC
  • 4.5% EDWARDS LIFESCIENCES CORP
  • 4.3% BAXTER INTERNATIONAL INC
  • 4.3% STRYKER CORP
  • 3.9% INTUITIVE SURGICAL INC
  • 3.5% BECTON DICKINSON & CO